275 related articles for article (PubMed ID: 35943661)
21. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE
J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
[TBL] [Abstract][Full Text] [Related]
22. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.
Principi N; Cozzali R; Farinelli E; Brusaferro A; Esposito S
J Infect; 2018 Feb; 76(2):111-120. PubMed ID: 29291933
[TBL] [Abstract][Full Text] [Related]
23. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome.
Xiao L; Liu Q; Luo M; Xiong L
Front Cell Infect Microbiol; 2021; 11():729346. PubMed ID: 34631603
[TBL] [Abstract][Full Text] [Related]
24. Microbiome and Its Role in Irritable Bowel Syndrome.
Pimentel M; Lembo A
Dig Dis Sci; 2020 Mar; 65(3):829-839. PubMed ID: 32026278
[TBL] [Abstract][Full Text] [Related]
25. Gut Microbiota and Chronic Constipation: A Review and Update.
Ohkusa T; Koido S; Nishikawa Y; Sato N
Front Med (Lausanne); 2019; 6():19. PubMed ID: 30809523
[No Abstract] [Full Text] [Related]
26. [Microbiota and irritable bowel syndrome: A critical inventory].
Enck P; Mazurak N
Z Gastroenterol; 2019 Jul; 57(7):859-870. PubMed ID: 31288282
[TBL] [Abstract][Full Text] [Related]
27. Dysbiosis in Functional Bowel Disorders.
Enck P; Mazurak N
Ann Nutr Metab; 2018; 72(4):296-306. PubMed ID: 29694952
[TBL] [Abstract][Full Text] [Related]
28. Marshall and Warren Lecture 2019: A paradigm shift in pathophysiological basis of irritable bowel syndrome and its implication on treatment.
Ghoshal UC
J Gastroenterol Hepatol; 2020 May; 35(5):712-721. PubMed ID: 32162356
[TBL] [Abstract][Full Text] [Related]
29. Treatments targeting the luminal gut microbiota in patients with irritable bowel syndrome.
Algera JP; Törnblom H; Simrén M
Curr Opin Pharmacol; 2022 Oct; 66():102284. PubMed ID: 36067685
[TBL] [Abstract][Full Text] [Related]
30. Targeting the gut microbiota for the treatment of irritable bowel syndrome.
Herndon CC; Wang YP; Lu CL
Kaohsiung J Med Sci; 2020 Mar; 36(3):160-170. PubMed ID: 31782606
[TBL] [Abstract][Full Text] [Related]
31. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
32. Food as Medicine: How to Influence the Microbiome and Improve Symptoms in Patients with Irritable Bowel Syndrome.
Vedantam S; Graff E; Khakoo NS; Khakoo NS; Pearlman M
Curr Gastroenterol Rep; 2023 Mar; 25(3):52-60. PubMed ID: 36763098
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic potential of an anaerobic cultured human intestinal microbiota, ACHIM, for treatment of IBS.
Benno P; Norin E; Midtvedt T; Hellström PM
Best Pract Res Clin Gastroenterol; 2019; 40-41():101607. PubMed ID: 31594647
[TBL] [Abstract][Full Text] [Related]
34. Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.
Peter J; Fournier C; Keip B; Rittershaus N; Stephanou-Rieser N; Durdevic M; Dejaco C; Michalski M; Moser G
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453528
[TBL] [Abstract][Full Text] [Related]
35. Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome.
Zhan K; Zheng H; Li J; Wu H; Qin S; Luo L; Huang S
Biomed Res Int; 2020; 2020():3828249. PubMed ID: 33274207
[TBL] [Abstract][Full Text] [Related]
36. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
[TBL] [Abstract][Full Text] [Related]
37. Potential role of fecal microbiota from patients with slow transit constipation in the regulation of gastrointestinal motility.
Ge X; Zhao W; Ding C; Tian H; Xu L; Wang H; Ni L; Jiang J; Gong J; Zhu W; Zhu M; Li N
Sci Rep; 2017 Mar; 7(1):441. PubMed ID: 28348415
[TBL] [Abstract][Full Text] [Related]
38. The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders.
Shin A; Preidis GA; Shulman R; Kashyap PC
Clin Gastroenterol Hepatol; 2019 Jan; 17(2):256-274. PubMed ID: 30153517
[TBL] [Abstract][Full Text] [Related]
39. Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome.
Choo C; Mahurkar-Joshi S; Dong TS; Lenhart A; Lagishetty V; Jacobs JP; Labus JS; Jaffe N; Mayer EA; Chang L
Am J Physiol Gastrointest Liver Physiol; 2022 Aug; 323(2):G134-G143. PubMed ID: 35726867
[TBL] [Abstract][Full Text] [Related]
40. Irritable bowel syndrome: a clinical review.
Chey WD; Kurlander J; Eswaran S
JAMA; 2015 Mar; 313(9):949-58. PubMed ID: 25734736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
